Needle Free Drug Delivery Devices Market

Needle Free Drug Delivery Devices Market: Industry Trends and Global Forecasts, till 2030 - Distribution by Type of Actuation Mechanisms (spring-based, gas powered and others), Route of Administration (subcutaneous, intramuscular and intradermal), Target Disease Indication (infectious diseases, diabetes, pain disorders and others), Product Usability (Disposable and Re-usable) and Key Geographical Regions (North America, Europe, Asia and Rest of the World)

  • Lowest Price Guaranteed From USD 4,499

  • Companies Covered
    445

  • Pages
    271

  • View Count
    24137

Needle Free Drug Delivery Devices Market Overview

The needle free drug delivery devices market is estimated to be worth $153 million in 2019 and is expected to grow at CAGR of 15% during the forecast period. In addition, the market for microneedle devices is expected to grow from around $40 million in 2025 to $206 million by 2030, at an annualized rate of close to 39%.

Chronic clinical conditions, such as diabetes, cardiovascular disorders, certain types of neurological disorders, and cancer, are considered to be among the leading causes of death and disability across the world. The Center for Managing Chronic Disease at the University of Michigan recently reported that over 50% of the global population is suffering from some form of chronic disease. Despite significant advances in drug / therapy development for the treatment of chronic diseases, there are several concerns related to the delivery of such therapeutics. Since most medications are developed for parenteral delivery, dosing errors and accidental needlestick injuries are some of the primary areas of concern. In fact, needle phobia is officially recognized as a medical condition by the American Psychiatric Association in its Diagnostic and Statistical Manual of Mental Disorders and is known to affect nearly 10% of the population.

The Needlestick Safety and Prevention Act, which was signed into law in the US in November 2000, encouraged the development of a variety of needleless syringes / safety syringes, such as needle-free injection systems, microneedle patches and microneedle pens. A sustained focus towards self-injection has also facilitated significant advances in drug development and administration. In fact, the self-injection devices market is characterized by the presence of a myriad of advanced and innovative drug delivery solutions, such as (in alphabetical order) autoinjectors, jet injectors, large volume wearable injectors, microneedles, pen injectors, needleless syringes and prefilled syringes. In fact, these drug delivery devices can prove to be potential vehicles for drug administration in disease outbreaks / pandemics (such as the one being faced due to the novel corona virus / COVID-19), where medical centers may not be equipped to deal with large masses for delivery of therapeutic / preventive vaccines (once these get approved).

This image highlights the context of Needle Free Injection Systems Market report This image presents current market landscape of Needle Free Injection Systems Market This image provides list of Microneedle Devices

The concept of needle free drug delivery is realized using a variety of actuation mechanisms (such as spring- or gas-powered devices) that are capable of facilitating the delivery of therapeutic interventions without the use of needles. On the other hand, microneedles are extremely minute needles (of the order of a few micrometers), which are designed to deliver drugs across the dermis. It is worth highlighting that such delivery systems are primarily based on the subcutaneous / intradermal and transdermal routes. The field of needleless drug delivery continues to witness significant advances, in terms of innovation in drug / therapy administration (such as dose tracking and real-time updates) and the development of compatible drug formulations. As a result, several stakeholders in the healthcare industry have developed interest in this upcoming field, and have launched product development / commercialization initiatives in the recent past. 

Key Companies in Needle Free Drug Delivery Devices Market

Examples of key companies engaged in needle free drug delivery devices market (which have also been profiled in this market report; the complete list of companies is available in the full report) include Inovio Pharmaceuticals, Medical International Technology, D'Antonio Consultants International, Enesi Pharma, PharmaJet, Inolife Sciences, NanoPass Technologies, 3M, Micropoint Technologies and Nemaura Pharma. This market report includes an easily searchable excel database of all the companies providing needle free injection systems, worldwide.

Recent Developments in Needle Free Drug Delivery Devices Market

Several recent developments have taken place in the field of needle free drug delivery devices market. We have outlined some of these recent initiatives below. These developments, even if they took place post the release of our market report, substantiate the overall market trends that have been outlined in our analysis.

  • In April 2023, PharmaJet Partner Gennova Biopharmaceuticals submitted data for its needle-free mRNA-based Omicron specific Covid-19 booster shot for Emergency Use Authorization (EUA) to the office of the Drug Controller General of India (DCGI) . 
  • In March 2023, NuGen Medical Devices published a report on its needle free injection device, InsuJetTM, claiming that InsuJet™ provides over 40% faster insulin uptake and significantly faster onset of action in diabetic patients compared to needle injections in multiple clinical studies performed in the Netherlands.

Scope of the Needle Free Drug Delivery Devices Market Report

The Needle Free Drug Delivery Devices Market report features an extensive study of the current market landscape, market size, market share, market growth, market trends, market value, market forecast, market outlook, statistics and future opportunities of the needle free drug delivery devices market.

This image highlights competitive analysis of Needle Free Injection Systems This image provides list of Likely Drug Candidates for Delivery via Needle-Free Injection Systems / Microneedles This image describes the attractiveness framework for needle-free injection systems and microneedle devices

Amongst other elements, the market research report includes:

  • A detailed review of the overall landscape of the needle-free injection systems market, featuring a comprehensive list of device developers and analysis based on a number of parameters, such as year of establishment, company size, geographical location, current development status of various products (under development and commercialized), details on intellectual property portfolio, route of administration (subcutaneous, intramuscular, intradermal and others), type of load (solid and liquid), usability (disposable and reusable), actuation mechanism (spring-based, gas-powered and others), capacity of the device (in terms of volume of drug delivered) and target disease areas.   
  • An overview of the current market landscape of microneedle devices, featuring a comprehensive list of device developers and analysis based on a number of parameters, such as year of establishment, company size, geographical location, current development status of various products (under development and commercialized), details on intellectual property portfolio, type of microneedle device (hollow, solid and dissolving), route of administration (subcutaneous, transdermal, intradermal and others), microneedle length and target disease areas.
  • A detailed product competitiveness analysis of both needle-free injection systems and microneedle devices, taking into consideration the supplier power (based on the year of establishment of developer company) and key product specifications. For needle-free injection systems, specifications, such as therapeutic area, route of administration, maximum device volume, usability, size of intellectual property portfolio, and commercial availability, were considered. For microneedles, specifications, such as therapeutic area, route of administration, length of microneedle, and size of intellectual property portfolio, were considered.
  • A list of marketed drugs / therapies and pipeline candidates that are anticipated to be developed in combination with needle free injectors and microneedles in the near future; the analysis is based on a variety of relevant parameters, such as (in alphabetical order) current status of development, dose concentration, dosing frequency, route of administration, type of dose (standard / weight dependent), expected patent expiry (relevant only for marketed drugs) and information on product sales (relevant only for marketed drugs).
  • An informed business portfolio analysis based on an attractiveness and competitiveness (AC) framework, highlighting the current worth of different types of needle-free injection systems and microneedle devices.
  • Elaborate profiles of prominent product developers engaged in the market. Each profile features a brief overview of the company, its financial information (if available), information on its product portfolio and recent developments.
  • A case study on the role of contract manufacturing organizations within the medical device industry. It includes a brief description of the various regulatory guidelines for medical devices and highlights the challenges associated with the manufacturing of such products. In addition, it features a list of contract manufacturers that claim to offer services for drug delivery devices and their geographical landscape. 

The key objective of needle free drug delivery devices market report is to provide a detailed market analysis in order to estimate the existing market size, market share, market growth, market trends, market value, market forecast, market outlook, statistics and future opportunity for market during the forecast period. Based on various parameters, such as number of marketed / pipeline products, existing price of devices (for commercially available products only) and estimated annual adoption rate, we have provided an informed estimate on the likely evolution of the market over the forecast period 2019-2030. For needle-free injection systems, the market report also features the likely distribution of the current and forecasted opportunity across [A] different types of actuation mechanisms (spring-based, gas powered and others), [B] routes of administration (subcutaneous, intramuscular and intradermal), [C] target disease indication (infectious diseases, diabetes, pain disorders and others), [D] product usability (disposable and re-usable) and [E] key geographical regions (North America, Europe, Asia and Rest of the World). Similarly, the projected future opportunity for microneedle devices has been analyzed across [A] various types of microneedle devices (hollow, solid and dissolving), [B] target disease indication (infectious diseases, osteoarthritis, pain disorders, cancer, and others), [C] type of intervention (vaccines, therapeutic agent and others), and [D] key geographical regions (North America, Europe, Asia and Rest of the World). In order to account for future uncertainties and to add robustness to our model, we have provided three market forecast scenarios, namely conservative, base and optimistic scenarios, representing different tracks of the industry’s growth.

This image highlights the geographical distribution of Microneedles and Needle Free Injection Systems Manufacturers This image provides information on the current and future market trends of Needle Free Injection Systems Market This image highlights the market segments of Microneedles Devices Market

The opinions and insights presented in the market report were influenced by discussions held with senior stakeholders in the industry. The market research report features detailed transcripts of interviews held with the following industry stakeholders:

  • CEO and Founder, Vaxess Technologies
  • CEO, Portal Instruments
  • Market Intelligence and Business Development Manager, Innoture

All actual figures have been sourced and analyzed from publicly available information forums and primary research discussions. Financial figures mentioned in this market research report are in USD, unless otherwise specified.

Frequently Asked Questions

Question 1: What are needle free drug delivery devices?

Answer: Needle free drug delivery devices encompass a wide range of drug delivery systems that administer the drug through the skin utilizing any of the forces including shock waves, pressure by gas or electrophoresis.

Question 2: How big is the needle free drug delivery devices market?

Answer: The needle free drug delivery devices market size is estimated to be worth $153 million in 2019.

Question 3: What is the projected market growth of the needle free drug delivery devices market?

Answer: The needle free drug delivery devices market is expected to grow at compounded annual growth rate (CAGR) of 15% during the forecast period 2019 – 2030.

Question 4: Who are the leading companies in the needle free drug delivery devices market?

Answer: Examples of key companies engaged in needle free drug delivery devices market (which have also been profiled in this market report; the complete list of companies is available in the full report) include Inovio Pharmaceuticals, Medical International Technology, D'Antonio Consultants International, Enesi Pharma, PharmaJet, Inolife Sciences, NanoPass Technologies, 3M, Micropoint Technologies and Nemaura Pharma.

Question 5: How many companies are currently engaged in developing needle free injection systems?

Answer: Presently, over 70 companies are engaged in the needle free drug delivery devices market, offering various needle free drug administering devices.

Question 6: How many needle free drug delivery devices are currently available / under development?

Answer: More than 100 such devices are currently available / under development.

Question 7: How many drug candidates are expected to be evaluated using the needle free drug delivery?

Answer: Over 300 drug candidates are expected to be evaluated using the devices developed by players engaged in the needle free drug delivery devices market.

PRICING DETAILS

This license grants the right of use of the purchased report to a single recipient only (normally the person who buys the report). You may access the material on your computer, as and when required, for your own personal use. You may also print Read more about Single-User License

This license grants the right of use of the purchased report by the employees of a business unit at a particular site/office location. The report may be accessed on the computer of any employee within the business unit. You may also print multiple Read more about One Location Site License

This license entitles the buyer of the report to share, distribute the report (either full or in part) with other employees of the same firm/enterprise. The report may be accessed by any employee of the enterprise and there is no limit on the Read more about Enterprise License

Discounts available for multiple report purchases
Click here to send an email to Roots Analysis team. sales@rootsanalysis.com